Designs for Group Sequential Phase II Clinical Trials

Recommendations

Approximately optimal designs for phase II clinical studies
Optimal two-stage group-sequential designs
Computation of optimal group sequential designs
Two-stage group sequential designs for comparative clinical trials
Optimal Designs for a Grouped Sequential Binomial Trial

Cited in

(27)

Two-stage group sequential designs for comparative clinical trials
A review of phase 2-3 clinical trial designs
On the maximum total sample size of a group sequential test about binomial proportions.
Optimal sequential designs in phase I studies
Methodology and application of adaptive and sequential approaches in contemporary clinical trials
Optimal adaptive two-stage designs for phase II cancer clinical trials
Computation of optimal group sequential designs
Two-Stage Designs with Additional Futility Tests for Phase II Clinical Trials with Heterogeneous Patient Populations
Optimal Designs for a Grouped Sequential Binomial Trial
MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION
Approximately optimal designs for phase II clinical studies
Improving the flexibility and efficiency of phase II designs for oncology trials
An Optimal Design for Screening Trials
Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
Design and Analysis of Phase II Cancer Trials: A Review of Statistical Methods and Guidelines for Medical Researchers
Assurance test and its equivalent truncated sequential test
Nearly optimal truncated group sequential test on binomial proportions
A class of confidence intervals for sequential phase II clinical trials with binary outcome
On the maximum total sample size of a group sequential test about bivariate binomial propor\-tions
Exact confidence limits after a group sequential single arm binary trial
Stopping rules for phase II clinical trials: an overview
Methods for proper handling of overrunning and underrunning in phase II designs for oncology trials
Designs for randomized phase II clinical trials with two treatment arms
A novel Phase II single-arm hybrid design to minimize trial duration and enhance subsequent Phase III trial success rate
Bayesian safety and futility monitoring in phase II trials using one utility-based rule
Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity
On Bayesian estimators in multistage binomial designs

This page was built for publication: Designs for Group Sequential Phase II Clinical Trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201547)